Heartflow is a medical technology company advancing the diagnosis and management of coronary artery disease, the #1 cause of death worldwide, using cutting-edge technology. The flagship product—an AI-driven, non-invasive cardiac test supported by the ACC/AHA Chest Pain Guidelines called the Heartflow FFRCT Analysis—provides a color-coded, 3D model of a patient’s coronary arteries indicating the impact blockages have on blood flow to the heart. Heartflow is the first AI-driven non-invasive integrated heart care solution across the CCTA pathway that helps clinicians identify stenoses in the coronary arteries (RoadMap™Analysis), assess coronary blood flow (FFRCT Analysis), and characterize and quantify coronary atherosclerosis (Plaque Analysis). Our pipeline of products is growing and so is our team; join us in helping to revolutionize precision heartcare.
Heartflow is a publicly traded company (HTFL) that has received international recognition for exceptional strides in healthcare innovation, is supported by medical societies around the world, cleared for use in the US, UK, Europe, Japan and Canada, and has been used for more than 400,000 patients worldwide.
The Director, Clinical Strategy is responsible for supporting HeartFlow’s efforts to generate clinical evidence. The Director, Medical Strategy will interact with HeartFlow’s Clinical, Technology, Medical Affairs and Commercial leadership to align clinical data generation strategy with technology, product, marketing, market access, and regulatory strategies. This will inform evidence generation, clinical validation, and market adoption of our AI-enabled products.
They will monitor trends in cardiology, clinical AI, digital health, regulatory, and reimbursement landscapes to inform clinical strategy. They will also collaborate effectively with clinical advisors, key opinion leaders, investigators and academic institutions to ensure strategy is both current and considerate of future-state.
This role requires a deep understanding of cardiovascular medicine, health technologies, clinical trial strategy, and the evolving landscape of digital health. It requires exceptional organizational and presentation skills, excellent attention to detail, and comfort working in a fast-paced start-up culture.
Job Responsibilities:
- Develop clinical evidence strategies for current and in-development products, aligned with product development and go-to-market plans.
- Collaborate with Clinical Leadership to design clinical trials and real-world evidence studies which validate the safety, efficacy, and impact across diverse stakeholders of Heartflow’s AI-enabled products.
- Support key scientific publication activities
- Provide credible engagement representing the company and its objectives to groups of experts, medical professional societies, patient representatives, regulatory bodies, and represent the company at national and international scientific meetings
- Lead appropriate compliant scientific/medical exchange and communication
- Establish and maintain strong working relationships with external advisors
- Partner with Medical Affairs and Clinical Leadership to plan and conduct Advisory Boards related to clinical trial strategy
Skills Needed:
- Strategic mindset with a focus on collaboration and excellence
- Ability to embrace patient-centric values, including highest ethical and compliance standards
- Ability to work in a smaller team environment with a willing, all hands-on deck attitude
- Work independently with minimal supervision
- Excellent presentation, written and verbal communication skills
- High attention to detail, accuracy, and quality and able to prioritize among multiple projects effectively
- Ability to travel up to 25% and cultural intelligence to work in international settings
Educational Requirements & Work Experience:
- >10 years in clinical research and strategy, with at least 8 years related to cardiovascular medicine in the pharmaceutical or medical device industry
- Advanced degree preferred
This position has an estimated base salary range of $200,000 to $260,000 per year, bonus, and equity. #LI-Hybrid; #LI-IB1
